T. C. Merigan
- Epidemiology top 0.5%
- Virology top 0.2%
- Infectious Diseases top 0.5%
- Immunology top 2%
- Molecular Biology top 10%
- Co-authors
- Lucy RasmussenErik De ClercqDavid KatzensteinMark A. WintersRobert W. ShaferAnthony L. CunninghamAnn M. ArvinWolfgang K. Joklik
- Topics
- HIV Research and Treatment (37 papers)Cytomegalovirus and herpesvirus research (34 papers)Herpesvirus Infections and Treatments (28 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
T. C. Merigan
125 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 117
- Epidemiology 2.5k
- Virology 1.8k
- Infectious Diseases 1.7k
- Immunology 1.5k
- Molecular Biology 885
Countries citing papers authored by T. C. Merigan
This map shows the geographic impact of T. C. Merigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. C. Merigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. C. Merigan more than expected).
Fields of papers citing papers by T. C. Merigan
This network shows the impact of papers produced by T. C. Merigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. C. Merigan. The network helps show where T. C. Merigan may publish in the future.
Co-authorship network of co-authors of T. C. Merigan
This figure shows the co-authorship network connecting the top 25 collaborators of T. C. Merigan. A scholar is included among the top collaborators of T. C. Merigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. C. Merigan. T. C. Merigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 195 | |
| 3 | 4 | |
| 4 | 74 | |
| 5 | 83 | |
| 6 | 7 | |
| 7 | 175 | |
| 8 | 25 | |
| 9 | 109 | |
| 10 | 7 | |
| 11 | 10 | |
| 12 | 133 | |
| 13 | 7 | |
| 14 | 16 | |
| 15 | 27 | |
| 16 | 18 | |
| 17 | 30 | |
| 18 | 44 | |
| 19 | 10 | |
| 20 | Treatment of cytomegalovirus infection with intravenous ARA-A | 1 |
About T. C. Merigan
T. C. Merigan is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 128 papers that have together received 5.6k indexed citations. Recurring topics across this work include HIV Research and Treatment (37 papers), Cytomegalovirus and herpesvirus research (34 papers) and Herpesvirus Infections and Treatments (28 papers). The work is most often cited by research in Virology (1.8k citations), Infectious Diseases (1.7k citations) and Epidemiology (2.5k citations). T. C. Merigan has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Lucy Rasmussen, Erik De Clercq, David Katzenstein, Mark A. Winters, Robert W. Shafer, Anthony L. Cunningham, Ann M. Arvin, Wolfgang K. Joklik, Mark Holodniy and Robert M. Nelson. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.